In vitro study of the binding of doxorubicin to heart.
Alvarez-Cedrón
L
L
Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Salamanca, Spain.
López
F G
FG
Lanao
J M
JM
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000378:metabolism / Q000493:pharmacokinetics*; D001667:Binding, Competitive; D004077:Digoxin / Q000493:pharmacokinetics; D004317:Doxorubicin / Q000378:metabolism / Q000493:pharmacokinetics*; D009206:Myocardium / Q000378:metabolism*; D020011:Protective Agents / Q000493:pharmacokinetics*; D051381:Rats; D017208:Rats, Wistar; D014700:Verapamil / Q000493:pharmacokinetics
D000903:Antibiotics, Antineoplastic; D020011:Protective Agents; D004077:Digoxin; D004317:Doxorubicin; D014700:Verapamil